Susceptibility of Helicobacter pylori isolates to metronidazole, clarithromycin and amoxycillin in vitro and in clinical treatment in Japan

Alimentary Pharmacology and Therapeutics

Volumn 11, Issue 6, 1997, Pages 1131-1136

  Miyaji, H ^a,d   Azuma, T ^a,b   Ito, S ^b   Suto, H ^a,b   Ito, Y ^b   Yamazaki, Y ^b   Sato, F ^b   Hirai, M ^b   Kuriyama, M ^c   Kato, T ^a,c   Kohli, Y ^c  

^a Second Department of Internal Medicine   (Japan)

^b Gifu College of Nursing   (Japan)

^c Aiseikai Yamashina Hospital   (Japan)

^d UNIVERSITY OF FUKUI   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; LANSOPRAZOLE; METRONIDAZOLE; OMEPRAZOLE; PROTON PUMP INHIBITOR;

ADULT; AGED; ARTICLE; BACTERIAL INFECTION; BACTERIUM ISOLATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DILUTION; DRUG SENSITIVITY; FEMALE; HELICOBACTER PYLORI; HUMAN; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; ORAL DRUG ADMINISTRATION; PEPTIC ULCER; PRIORITY JOURNAL;

EID: 15144349697     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.1997.00258.x     Document Type: Article

References (33)

1. Marshall BJ, McGcchie DB. Rogers PA, Glancy RJ. Pyloric Campylobacter infection and gastroduodenal disease. Med J Aust 1985: 142: 439-44.
2. NIH Consensus Conference. Helicobacter pykri in peptic ulcer disease. J Am Med Assoc 1994; 272: 65-9.
3. Marshall BJ, Goodwin CS, Warren JR, et al Prospective double blind trial of duodenal ulcer relapse after eradication of Cnmpylobacter pylori. Lancet 1988; 2: 1437-42.
4. Graham DY. Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer. Ann Intern Med 1992: 116: 705-8.
5. Logan RPH, Gummett PA, Misiewics JJ. Karim QN, Walker MM, Baron JH. One week eradication regimen for Helicobacter pylori. Lancet 1991: 338: 249-52.
6. Bell GD, Powell K, Burridge SM, et al. Experience with 'triple' anti-Helicobacter pylori eradication therapy: side-effects and the importance of testing the prc-treatment bacterial isolate for metronidazole resistance. Aliment Pharmacol Ther 1992; 6: 427-35.
7. Rauws EA, Tytgat GN. Cure of duodenal ulcer associated with eradication of Helicobacter pylori. Lancet 1990; 335: 1233-5.
8. Yousfi MM, el Zimaity HM, al Assi MT, Cole RA, Genta RM, Graham DY. Metronidazole, omeprazole and clarithromycin: an effective combination therapy for Helicobacter pylori infection. Aliment Pharmacol Ther 1995; 9: 209-12.
9. Jaup BH, Norrby A. Low dose, short term triple therapy for cure of Helicobacter pylori infection and healing of peptic ulcers. Am] Gastroenterol 1995; 90: 943-5.
10. Chiba N. Omeprazole and clarithromycin with and without metronidazole for the eradication of Helicobacter pylori. Am J Gastroenterol 1996; 91: 2139-43.
11. Goodwin CS, Marshall BJ, Blincow ED, Wilson DH, Blackbourn S, Phillips M. Prevention of nitroimidazole resistance in Campylobacter pylori by coadministration of colloidal bismuth subcitrate: clinical and in vitro studies. J Clin Pathol 1988; 41: 207-10.
12. Logan RPH, Gummett PA, Schaufelbcrger HD, et al. Eradication of Helicobacter pylori with clarithromycin and omeprazole. Gut 1994; 35: 323-6.
13. Glupczynski Y, Burette A, De Koster E. Metronidazole resistance in Helicobacter pylori. Lancet 1990; 335: 976-7.
14. Rautelin H, Seppala K, Renkonen ÖL, Vainio U, Kosuken TU. Role of metronidazole resistance in therapy of Helicobacter pylori infections. Antimicrob Agents Chemother 1992; 36: 163-6.
15. Lamouliatte H, Cayla R, Megraud F, et al. Randomized controlled trial with omeprazole and antibiotics in a combined treatment for Helicobacter pylori eradication. Preliminary results. Acta Castro Enterologica Belgica 1993; 56(Suppl.): 139 (Abstract).
16. Midolo PD, Turnidge J, Lambert JR, Bell JM. Validation of a modified Kirby-Bauer disk diffusion method for metronidazole susceptibility testing of Helicobacter pylori. Diagn Microbiol Infect Dis 1995:21: 135-40.
17. Xia HX. Buckley M, Keane CT, O'Morain CA. Clarithromycin resistance in Helicobacter pylori: prevalence in untreated dys-peptic patients and stability in vitro. J Antimicrob Chemothcr 1996; 37: 473-81.
18. Kohli Y, Kato T, hvaki M. Ito S. Suzuki K. Endoscopie diagnosis of Helicobacter pylori distribution in gastric mucosa of patients with chronic gastritis. Eur J Gastroenterol Hepatol 1993; 5(Suppl. 1): S127-31.
19. Miyaji H, Ito S, Azuma T. et al Effects of Helicobacter pylori: eradication therapy on hyperammonaemia in patients with liver cirrhosis. Gut 1997; 40: 726-30.
20. Lambert T, Megraud F, Gerbaud G. Courvalin P. Susceptibity of Campylobacter pyloridis to 20 antimicrobial agents. Antimicrob Agents Chemother 1986; 30: 510-11.
21. Glupczynski Y. Resuis of multicentre European survey in 1991 of metronidazole resistance in Helicobacter pylori. Eur J Clin Microbiol Infect Dis 1992; 11: 777-81.
22. Midolo PD. Korman MG. Turnidge JD, Lambert JR. Helicobacter pylori resistance to tetracycline. Lancet 1996; 347: 1194-5.
23. Rautelin H, Seppala K, Renkonen OV/Vainio U, Kosunen TU. Role of metronidazole resistance in therapy of Helicobacter pylori infections. Antimicrob Agents Chemother 1992; 36: 163-6.
24. Midolo PD, Lambert JR. Turnidge J. Metronidazole resistance: A predictor of failure in Helicobacter pylori eradication by triple therapy. J Gastroenterol Hepatol 1996; 11: 290-2.
25. Weldon MJ, Broadbent A, Chambers S, Mistry R. Ranganath L, Gould SR. A seven-day Helicobacter pylori treatment regimen using clarithromycin, omeprazole and tripotassium dicitrato bismuthate. Aliment Pharmacol Ther 1996; 10: 279-83.
26. Megraud F. H. pylori resistance to antibiotics. In: Hunt RH, Tygat GNJ, eds. Helicobacter pylori: Basic Mechanism to Clinical Cure. Proceedings of Internal Symposium, Florida, USA, 1993: 570-83.
27. Xia HX, Buckley M, Hyde D, Keane CT, O'Morain CA. Effect of antibiotic-resistance on clarithromycin-combined triple therapy for Helicobacter pylori. Gut 1995; 37(Suppl. 1): A55(Abstract).
28. Westblom T, Duriex D. Enhancement of antibiotics concentration of He/irotaerpiy/oriinfections. Dig Dis Sei 1991; 36:25-8.
29. Gustavson LE, Kaiser JF, Edmonds AL, Locke CS, DeBartolo ML, Schmeck DW. Effect of omeprazole on concentrations of clarithromycin in plasma and gastric tissue at steady state. Antimicrob Agents Chemother 1995; 39: 2078-83.
30. Goddard AF, Jessa MJ, Barrett DA, et al. Effect of omeprazole on the distribution of metronidazole, amoxicillin, and clarithromycin in human gastric juice. Gastroenterology 1996; 111: 358-67.
31. O'Riordan T, Mathai E, Tobin E, et al. Adjuvant antibiotic therapy in duodenal ulcers treated with colloidal bismuth subcitrate. Gut 1990; 31: 999-1002.
32. Glupczynski Y, Labbe M, Hansen W, Crokaert F, Yourassowsky E. Evaluation of the E-test for quantitative antimicrobial susceptibility testing of Helicobacter pylori. J Clin Microbiol 1991; 29: 2072-5.
33. Weel JFL, Hulst RWM, Gerrits Y, et al. Heterogeneity in susceptibility to metronidazole among Helicobacter pylori isolates from patients with gastritis or peptic ulcer disease. J Clin Microbiol 1996; 34: 2158-62.